BioCentury | Jul 9, 2020
Finance

Forbion catering to abundance of maturing European biotechs with new growth fund

...Carlo Incerti, a former CMO at the Genzyme unit of Sanofi (Euronext:SAN; NASDAQ:SNY), and former Cubist Pharmaceuticals Inc....
BioCentury | Jan 14, 2020
Finance

Tyra raises $50M series A for cancer drug resistance

...member of the protein crystallography group at Trius Therapeutics Inc. until it was acquired by Cubist Pharmaceuticals Inc....
BioCentury | Jun 14, 2019
Company News

Management tracks: Flatiron picks Unum’s Vasconcelles to succeed Abernethy; plus Quell, Lytix and more

...Therapeutics LLC (Cambridge, Mass.) hired Joseph Farmer as COO. He was chief corporate counsel at Cubist Pharmaceuticals Inc....
BioCentury | May 21, 2019
Company News

Merck bets on HIF2As with Peloton takeout ahead of planned listing

...made in an acquisition of a therapeutics developer since the pharma’s takeout of antibiotics company Cubist Pharmaceuticals Inc....
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...as chairman. He succeeds Richard White who stood down in December. Vink was COO at Cubist Pharmaceuticals Inc....
BioCentury | Dec 1, 2017
Clinical News

CHMP recommends pediatric label expansion for Merck's Cubicin

...rights to the product from Eli Lilly and Co. (NYSE:LLY) through its 2015 acquisition of Cubist Pharmaceuticals Inc....
...& Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Cubicin daptomycin (MK-3009) (formerly LY146032) Business: Infectious Elizabeth S. Eaton Cubicin daptomycin MK-3009 Cubist Pharmaceuticals Inc. Eli...
BioCentury | Oct 24, 2017
Company News

Management tracks: Five Prime, CytoSen

...a consultant since 2015, when he was head of infection prevention technology & services at Cubist Pharmaceuticals Inc....
BioCentury | Sep 22, 2017
Financial News

Flagship Pioneering unveils microbiome-focused company Kaleido

...undisclosed funding round. Kaleido also named Mike Bonney CEO and chairman. He was CEO of Cubist Pharmaceuticals Inc....
BioCentury | Sep 18, 2017
Financial News

Flagship Pioneering unveils microbiome-focused company

...undisclosed funding round. Kaleido also named Mike Bonney CEO and chairman. He was CEO of Cubist Pharmaceuticals Inc....
BioCentury | Mar 10, 2017
Finance

A fever for infectious

...Spero’s senior management are veterans of antibiotics company Cubist Pharmaceuticals Inc. Merck & Co. Inc. (NYSE:MRK) acquired Cubist...
Items per page:
1 - 10 of 916
BioCentury | Jul 9, 2020
Finance

Forbion catering to abundance of maturing European biotechs with new growth fund

...Carlo Incerti, a former CMO at the Genzyme unit of Sanofi (Euronext:SAN; NASDAQ:SNY), and former Cubist Pharmaceuticals Inc....
BioCentury | Jan 14, 2020
Finance

Tyra raises $50M series A for cancer drug resistance

...member of the protein crystallography group at Trius Therapeutics Inc. until it was acquired by Cubist Pharmaceuticals Inc....
BioCentury | Jun 14, 2019
Company News

Management tracks: Flatiron picks Unum’s Vasconcelles to succeed Abernethy; plus Quell, Lytix and more

...Therapeutics LLC (Cambridge, Mass.) hired Joseph Farmer as COO. He was chief corporate counsel at Cubist Pharmaceuticals Inc....
BioCentury | May 21, 2019
Company News

Merck bets on HIF2As with Peloton takeout ahead of planned listing

...made in an acquisition of a therapeutics developer since the pharma’s takeout of antibiotics company Cubist Pharmaceuticals Inc....
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...as chairman. He succeeds Richard White who stood down in December. Vink was COO at Cubist Pharmaceuticals Inc....
BioCentury | Dec 1, 2017
Clinical News

CHMP recommends pediatric label expansion for Merck's Cubicin

...rights to the product from Eli Lilly and Co. (NYSE:LLY) through its 2015 acquisition of Cubist Pharmaceuticals Inc....
...& Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Cubicin daptomycin (MK-3009) (formerly LY146032) Business: Infectious Elizabeth S. Eaton Cubicin daptomycin MK-3009 Cubist Pharmaceuticals Inc. Eli...
BioCentury | Oct 24, 2017
Company News

Management tracks: Five Prime, CytoSen

...a consultant since 2015, when he was head of infection prevention technology & services at Cubist Pharmaceuticals Inc....
BioCentury | Sep 22, 2017
Financial News

Flagship Pioneering unveils microbiome-focused company Kaleido

...undisclosed funding round. Kaleido also named Mike Bonney CEO and chairman. He was CEO of Cubist Pharmaceuticals Inc....
BioCentury | Sep 18, 2017
Financial News

Flagship Pioneering unveils microbiome-focused company

...undisclosed funding round. Kaleido also named Mike Bonney CEO and chairman. He was CEO of Cubist Pharmaceuticals Inc....
BioCentury | Mar 10, 2017
Finance

A fever for infectious

...Spero’s senior management are veterans of antibiotics company Cubist Pharmaceuticals Inc. Merck & Co. Inc. (NYSE:MRK) acquired Cubist...
Items per page:
1 - 10 of 916